Polymyalgia Rheumatica in Association with Remitting Seronegative Sinovitis with Pitting Edema: a Neoplastic Warning

Overview

Journal Can Geriatr J

Specialty Geriatrics

Date 2017 Jul 11

PMID 28690709

Citations 8

Authors

Ciro Manzo

Maria Natale

Affiliations

Soon will be listed here.

Citing Articles

Remitting Seronegative Symmetrical Synovitis With Pitting Oedema Associated With Malignancy: A Case Report.

Matos M, Rocha J, Matos M, Brito M, Ferreira S Cureus. 2024; 16(6):e62980.

PMID: 39044899 PMC: 11265790. DOI: 10.7759/cureus.62980.

Polymyalgia rheumatica: An update (Review).

Florescu M, Bobirca F, Florescu A, Padureanu V, Bobirca A, Ciurea P Exp Ther Med. 2023; 26(6):543.

PMID: 37928511 PMC: 10623218. DOI: 10.3892/etm.2023.12242.

Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome with underlying history of malignancy.

Kim K, Marvil C, Adhyaru B Clin Case Rep. 2023; 11(5):e7330.

PMID: 37180322 PMC: 10167620. DOI: 10.1002/ccr3.7330.

Polymyalgia rheumatica and cancer: surveillance duration and other points to ponder.

Manzo C, Nune A Reumatologia. 2023; 61(1):1-3.

PMID: 36998582 PMC: 10044035. DOI: 10.5114/reum.2023.124336.

Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome mimicking symptoms of polymyalgia rheumatica: a case report.

Tarasiuk-Stanislawek K, Dumusc A, Favrat B, Kokkinakis I J Med Case Rep. 2022; 16(1):334.

PMID: 36028914 PMC: 9419361. DOI: 10.1186/s13256-022-03535-z.

References

Muller S, Hider S, Helliwell T, Bailey J, Barraclough K, Cope L . The epidemiology of polymyalgia rheumatica in primary care: a research protocol. BMC Musculoskelet Disord. 2012; 13:102. PMC: 3406947. DOI: 10.1186/1471-2474-13-102. View

Healey L . Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum. 1984; 13(4):322-8. DOI: 10.1016/0049-0172(84)90012-x. View

Manger B, Schett G . Paraneoplastic syndromes in rheumatology. Nat Rev Rheumatol. 2014; 10(11):662-70. DOI: 10.1038/nrrheum.2014.138. View

Kermani T, Schafer V, Crowson C, Hunder G, Gabriel S, Ytterberg S . Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res (Hoboken). 2010; 62(2):149-54. PMC: 2874240. DOI: 10.1002/acr.20062. View

Mittal K, Ebos J, Rini B . Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. Semin Oncol. 2014; 41(2):235-51. DOI: 10.1053/j.seminoncol.2014.02.007. View

Dasgupta B, Cimmino M, Maradit-Kremers H, Schmidt W, Schirmer M, Salvarani C . 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012; 71(4):484-92. PMC: 3298664. DOI: 10.1136/annrheumdis-2011-200329. View

Li H, Altman R, Yao Q . RS3PE: Clinical and Research Development. Curr Rheumatol Rep. 2015; 17(8):49. DOI: 10.1007/s11926-015-0525-0. View

Haga H, Eide G, Brun J, Johansen A, Langmark F . Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol. 1993; 20(8):1335-9. View

Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M . RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis. 2005; 64(11):1653-5. PMC: 1755286. DOI: 10.1136/ard.2004.032995. View

10.

Karmacharya P, Donato A, Aryal M, Ghimire S, Pathak R, Shah K . RS3PE revisited: a systematic review and meta-analysis of 331 cases. Clin Exp Rheumatol. 2016; 34(3):404-15. View

11.

Guichard A, Vignon G . Metastatic cancer polyradiculoneuritis; Multiple paralysis of the cranial and spinal nerves by microscopic generalization of an epithelioma of the colutein. J Med Lyon. 1949; 30(700):197-207. View

12.

Muller S, Hider S, Belcher J, Helliwell T, Mallen C . Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis. 2013; 73(10):1769-73. PMC: 4173739. DOI: 10.1136/annrheumdis-2013-203465. View

13.

McCarty D, ODuffy J, Pearson L, Hunter J . Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA. 1985; 254(19):2763-7. View

14.

Russell E, Hunter J, Pearson L, McCarty D . Remitting, seronegative, symmetrical synovitis with pitting edema--13 additional cases. J Rheumatol. 1990; 17(5):633-9. View

15.

Jordan K, Croft P . Mortality and cancer in patients with new musculoskeletal episodes: a cohort study. Br J Gen Pract. 2010; 60(572):e105-11. PMC: 2828857. DOI: 10.3399/bjgp10X483526. View

16.

Myklebust G, Wilsgaard T, Jacobsen B, Gran J . No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol. 2002; 29(10):2143-7. View

17.

Rooney P, Rooney J, Balint G, Balint P . Polymyalgia rheumatica: 125 years of epidemiological progress?. Scott Med J. 2014; 60(1):50-7. DOI: 10.1177/0036933014551115. View

18.

Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K . Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford). 2010; 49(6):1158-63. DOI: 10.1093/rheumatology/keq040. View

19.

Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L . Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis. 1999; 58(4):230-6. PMC: 1752869. DOI: 10.1136/ard.58.4.230. View

20.

Manzo C, Natale M . Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set. Open Access Rheumatol. 2016; 8:93-95. PMC: 5098681. DOI: 10.2147/OARRR.S116036. View